← Eichor
Condition: Intestinal Failure Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Intestinal Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Abdominal Wall Transplant
NA · 1 location(s) · Duke University · NCT03310905
The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis
Phase N/A · 1 location(s) · Humanitas Clinical and Research Center · NCT06691061
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Phase 2 · 14 location(s) · Hanmi Pharmaceutical Company Limited · NCT04775706
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Phase 3 · 23 location(s) · Zealand Pharma · NCT07197944
The Gut Microbiome in Chronic Heart Failure
NA · 1 location(s) · Nazarbayev University · NCT06573892
Fecal Microbiota Transplantation for Liver Failure
NA · 1 location(s) · Ningbo Medical Center Lihuili Hospital · NCT05170971
Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
Phase 2 · 1 location(s) · Shanghai Pudong Hospital · NCT07106034
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
NA · 8 location(s) · SterileCare Inc. · NCT05879835
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Phase N/A · 14 location(s) · Boston Children's Hospital · NCT04629014
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Co
Phase 2 · 8 location(s) · Napo Therapeutics, S.p.A. · NCT06904872
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
NA · 1 location(s) · University of Michigan · NCT06337812
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06763029
AI-driven Total Parenteral Nutrition Platform
NA · 1 location(s) · Takeoff41, Inc. · NCT07414576
Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268
Comparing Three Rescue Bowel Preparation Regimens for Colonoscopy After Failed Cleansing
NA · 1 location(s) · Ospedale San Pio · NCT07557173
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in A
NA · 6 location(s) · Eclipse Regenesis, Inc. · NCT05535361
VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07202910
Weaning is Winning? (WeWin Study)
Phase N/A · 1 location(s) · The Hospital for Sick Children · NCT06525753
Resting Energy Expenditure by Gastrointestinal Functional Status
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07714499
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Par
Phase 2/Phase 3 · 17 location(s) · Protara Therapeutics · NCT06910943
Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease
NA · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT07621367
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Phase 3 · 1 location(s) · Ralf Hofheinz · NCT04495088
Microbiota-Inflammation-Brain Axis in Heart Failure: New Functional Food for the Prevention of undeRnutrition in Older
NA · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT07076329
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
Phase 2 · 13 location(s) · NorthSea Therapeutics B.V. · NCT05919680
Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative
Phase 3 · 71 location(s) · Pierre Fabre Medicament · NCT03394365
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
Phase N/A · 3 location(s) · University of Florida · NCT06606119
Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
Phase N/A · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05068531
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.